Gerry is a commercial and intellectual property partner with over 25 years’ experience gained in senior in-house and advisory roles across multiple sectors. Prior to joining Keystone, Gerry served as the UK General Counsel for Lonza, a global supplier to the pharmaceutical, biotech, and specialty ingredients industries.
Gerry specialises specifically in the life sciences sector, where he has spent more than two decades advising on complex commercial, intellectual property, and technology matters. He is experienced in negotiating development and manufacturing agreements, overseeing international manufacturing projects, advising on gene expression technology licensing, and supporting clients with research and collaboration agreements.
His clients include multinational pharmaceutical companies and early-stage biotech businesses.
Expertise
- Commercial agreements
- Development
- Manufacturing
- R&D collaborations
- Cross-border contracts
- Intellectual property
- Structuring agreements
- Licensing
- Biologics
- Technology transfer
- Life sciences
- Biopharmaceuticals
- Small molecules
- Cell & gene therapies
Experience
Commercial Contracts
- Advised on multiple large-scale biologics’ manufacturing agreements across different facilities worldwide.
- Advised on product development agreements, encompassing specification targets, raw material supplies, and quality agreements.
- Advised on joint venture agreements for the manufacture of biosimilars and for shared manufacturing facilities.
Intellectual Property
- Advised on the creation of a royalty monetisation programme.
- Advised on the protection of know-how used in the development of manufacturing processes.
- Advised on collaboration agreements with pharma companies and the appropriate allocation of IP.
Licensing
- Advised a large engineering company on trade-mark licensing agreements in the automotive sector.
- Advised on out-licensing agreements for pharmaceutical manufacturing processes.
- Advised a large pharmaceutical manufacturer on a technology collaboration agreement with a commercial customer.
- Advised a pharmaceutical company on a research & development agreement with an American University.
Healthcare & Life Sciences
- Advised on numerous biopharmaceutical Development and Manufacturing Services Agreements (DMSAs) and the accompanying Quality Agreement.
- Advised on regulatory matters relating to biopharmaceutical facility inspections by the FDA, MHRA, and other regulatory bodies.
- Advised on a joint venture established for the global manufacture of biosimilars.
- Advised on the sale of a large-scale pharmaceutical manufacturing facility in Singapore.
- Advised on the purchase of a large-scale pharmaceutical manufacturing facility in Spain.
- Advised a pharmaceutical manufacturer on a technology collaboration agreement with a commercial customer.
- Advised on numerous patent and know-how licences relating to cell lines.
- Advised on the creation of a royalty monetisation programme.
Please note: The experience list above may include examples of work completed prior to joining Keystone Law.
Recognition
Chairman of the Thomson Reuters 3rd Annual Life Sciences Law Forum
Member of the Pharmaceutical Licensing Group (PLG)
Career
Gerry qualified as a solicitor in 1991. Prior to joining Keystone Law in 2025, he worked at the following firms:
- Ascend Advanced Therapies
- Lonza
- Vickers plc